Biocube Stock Today
| BICB Stock | USD 0.0001 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressRisky
|
BioCube is trading at 1.0E-4 as of the 30th of January 2026, a No Change since the beginning of the trading day. The stock's open price was 1.0E-4. BioCube has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 1st of November 2025 and ending today, the 30th of January 2026. Click here to learn more.
BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. The company has 44.84 M outstanding shares. More on BioCube
Moving against BioCube Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioCube Pink Sheet Highlights
| Business Concentration | Shell Companies, Financial Services (View all Sectors) |
BioCube [BICB] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioCube's market, we take the total number of its shares issued and multiply it by BioCube's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioCube conducts business under Financial Services sector and is part of Shell Companies industry. The entity has 44.84 M outstanding shares.
BioCube currently holds about 39 in cash with 210 of positive cash flow from operations.
Check BioCube Probability Of Bankruptcy
Ownership AllocationBioCube holds a total of 44.84 Million outstanding shares. Almost 99.93 percent of BioCube outstanding shares are held by general public with 0.069 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioCube Ownership Details
BioCube Stock Against Markets
BioCube Pink Sheet Analysis Notes
The company recorded a loss per share of 0.02. BioCube had not issued any dividends in recent years. The entity had 1:15 split on the 2nd of September 2009. BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. Biocube is traded on OTC Exchange in the United States.The quote for BioCube is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BioCube please contact the company at 888-827-7901.BioCube Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. BioCube's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding BioCube or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| BioCube generated a negative expected return over the last 90 days | |
| BioCube has high historical volatility and very poor performance | |
| BioCube has some characteristics of a very speculative penny stock | |
| BioCube has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (534.8 K) with profit before overhead, payroll, taxes, and interest of 0. |
BioCube Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.14 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioCube's market, we take the total number of its shares issued and multiply it by BioCube's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
BioCube technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BioCube Price Movement Analysis
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. BioCube Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe BioCube price patterns.
BioCube Outstanding Bonds
BioCube issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BioCube uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BioCube bonds can be classified according to their maturity, which is the date when BioCube has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BIO 33 15 MAR 27 Corp BondUS090572AR99 | View | |
| BIO 37 15 MAR 32 Corp BondUS090572AQ17 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioCube without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run USA ETFs Now
USA ETFsFind actively traded Exchange Traded Funds (ETF) in USA |
| All Next | Launch Module |
Other Information on Investing in BioCube Pink Sheet
BioCube financial ratios help investors to determine whether BioCube Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioCube with respect to the benefits of owning BioCube security.